Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATNon-Current ReceivablesOther Gross PP&E AdjustmentsShort-Term Debt issuances
Ratios

Dr Reddys Laboratories (RDY) Depreciation & Amortization (IS) (2016 - 2025)

Historic Depreciation & Amortization (IS) for Dr Reddys Laboratories (RDY) over the last 6 years, with Q3 2025 value amounting to $57.9 million.

  • Dr Reddys Laboratories' Depreciation & Amortization (IS) rose 2198.76% to $57.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.7 million, marking a year-over-year increase of 1575.21%. This contributed to the annual value of $201.8 million for FY2025, which is 1257.34% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Depreciation & Amortization (IS) stood at $57.9 million for Q3 2025, which was up 2198.76% from $55.7 million recorded in Q2 2025.
  • Dr Reddys Laboratories' 5-year Depreciation & Amortization (IS) high stood at $57.9 million for Q3 2025, and its period low was $45.7 million during Q2 2024.